Anthera Pharmaceuticals Inc (ANTH)

Currency in USD
0.0001
0.0000(0.00%)
Delayed Data·
Trading near 52-week Low
ANTH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.00010.0001
52 wk Range
0.00010.0010
Key Statistics
Prev. Close
0.0001
Open
0.0001
Day's Range
0.0001-0.0001
52 wk Range
0.0001-0.001
Volume
-
Average Volume (3m)
9.69K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANTH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Nov 18, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ANTH Income Statement

Compare ANTH to Peers and Sector

Metrics to compare
ANTH
Peers
Sector
Relationship
P/E Ratio
0.0x−1.6x−0.3x
PEG Ratio
0.000.000.00
Price/Book
0.0x2.4x2.6x
Price / LTM Sales
0.0x6.8x2.8x
Upside (Analyst Target)
0.0%203.8%64.7%
Fair Value Upside
Unlock12.9%9.6%Unlock

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.

People Also Watch

21.280
AMRX
+1.24%
0.011
LADX
0.00%
313.09
LGND
+1.55%
38.34
AZTA
+3.15%
43.52
VCEL
+1.12%

FAQ

What Is the Anthera (ANTH) Stock Price Today?

The Anthera stock price today is 0.0001 USD.

What Stock Exchange Does Anthera Trade On?

Anthera is listed and trades on the OTC Markets.

What Is the Stock Symbol for Anthera?

The stock symbol for Anthera is "ANTH."

What Is the Anthera Market Cap?

As of today, Anthera market cap is 2.6200K USD.

From a Technical Analysis Perspective, Is ANTH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Anthera Stock Split?

Anthera has split 2 times.

How Many Employees Does Anthera Have?

Anthera has 21 employees.

What is the current trading status of Anthera (ANTH)?

As of Oct 27, 2026, Anthera (ANTH) is trading at a price of 0.0001 USD, with a previous close of 0.0001 USD. The stock has fluctuated within a day range of 0.0001 USD to 0.0001 USD, while its 52-week range spans from 0.0001 USD to 0.0010 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.